Westbourne Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Westbourne Investments's BMY Position: Q2 2026 in Review
Westbourne Investments increased its Bristol-Myers Squibb (BMY) stake by 0.35% in Q2 2026, buying an estimated $861 and bringing the position to 4,256 shares worth $245K. The position accounts for 0.1% of the portfolio, ranked #124.
Westbourne Investments first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.16M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Westbourne Investments held 4,256 shares of Bristol-Myers Squibb worth $245K as of Q2 2026.
- Westbourne Investments bought 15 Bristol-Myers Squibb shares in Q2 2026, an estimated $861.
- Bristol-Myers Squibb made up 0.1% of Westbourne Investments's portfolio in Q2 2026, its #124 holding.
- Westbourne Investments first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
- Westbourne Investments's Bristol-Myers Squibb position peaked at $2.16M in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.